Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). [Phase 2]
This Phase 2 trial compares clofarabine alone versus clofarabine with low-dose cytarabine in previously untreated acute myeloid leukemia and…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients [Phase 2]
Phase 2 trial evaluating azacitidine with valproic acid versus cytarabine in patients with acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update evaluating treatment for children and adolescents with refractory or relapsed acute myeloid leukemia; the study status …
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia [Phase 2]
This update reports results from a Phase 2 trial evaluating a risk-oriented therapeutic strategy in adults with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing cytarabine with arsenic trioxide versus cytarabine alone in elderly patients with acute myeloid leukemia was termi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) [Phase 2]
Phase 2 clinical trial update evaluating Clofarabine for older patients with newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 study evaluating all-trans retinoic acid and bryostatin in patients with acute myeloid leukemia and myelodysplastic syndromes has co…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia [Phase 1]
Phase 1 clinical trial evaluating vaccination with autologous acute myeloid leukemia cells in adults with advanced myelodysplastic syndromes…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia [Phase 1]
Phase 1 multicenter trial evaluating 9-aminocamptothecin (9-AC) in patients with refractory leukemia, including acute myeloid leukemia and a…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating high-dose cytarabine (HDAC) with interleukin-2 (IL-2) for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial evaluates combination chemotherapy followed by filgrastim or sargramostim in patients with relapsed or refractory acute myel…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating irinotecan and cytarabine in patients with refractory or recurrent acute myeloid leukemia or chronic myeloid leukem…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A completed Phase I/II trial evaluating the combination of 5-azacytidine with cytarabine in patients with relapsed/refractory acute myeloid …
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
This is a Phase 2 clinical trial evaluating combination chemotherapy for newly diagnosed acute myeloid leukemia. The study, sponsored by The…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating treosulfan with fludarabine as conditioning before donor stem cell transplant in younger patients with AML, ALL, …
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting [Phase 2]
A Phase 2 randomized trial compared palonosetron to ondansetron for the prevention of chemotherapy-induced nausea and vomiting in patients w…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating AS1411 with cytarabine for primary refractory or relapsed acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. [Phase 2]
Phase 2 study of the farnesyl transferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. The trial sta…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML [Phase 1]
Phase I study evaluating AZD2171 in relapsed/refractory acute myeloid leukemia and in elderly patients with de novo or secondary AML has com…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 pharmacokinetic and efficacy study evaluating Amonafide L-malate (AS1413) in combination with Cytarabine for acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia [Phase 1]
Phase 1 trial assessing AZD1152 (barasertib) in relapsed acute myeloid leukemia, focusing on safety, tolerability, pharmacokinetics, and pre…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML) [Phase 2]
This document reports a Phase 2 trial of Modified-FLAI induction and consolidation chemotherapy in elderly patients with Acute Myeloid Leuke…
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of pentostatin with low-dose total body irradiation followed by allogeneic peripheral …
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) [Phase 1, Phase 2]
This trial update reports on the safety and anti-disease activity of CHR-2797 (tosedostat) in elderly and/or treatment-refractory patients w…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) [Phase 1]
This open-label, single-centre Phase 1 mass balance C-14 study in patients with acute myeloid leukemia has completed.